208 related articles for article (PubMed ID: 35563462)
1. Development and Biochemical Characterization of Self-Immolative Linker Containing GnRH-III-Drug Conjugates.
Schuster S; Juhász É; Halmos G; Neundorf I; Gennari C; Mező G
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563462
[TBL] [Abstract][Full Text] [Related]
2. Oxime bond-linked daunorubicin-GnRH-III bioconjugates exert antitumor activity in castration-resistant prostate cancer cells via the type I GnRH receptor.
Montagnani Marelli M; Manea M; Moretti RM; Marzagalli M; Limonta P
Int J Oncol; 2015 Jan; 46(1):243-53. PubMed ID: 25351635
[TBL] [Abstract][Full Text] [Related]
3. Improved In Vivo Anti-Tumor and Anti-Metastatic Effect of GnRH-III-Daunorubicin Analogs on Colorectal and Breast Carcinoma Bearing Mice.
Ranđelović I; Schuster S; Kapuvári B; Fossati G; Steinkühler C; Mező G; Tóvári J
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31557968
[TBL] [Abstract][Full Text] [Related]
4. Improved in vivo antitumor effect of a daunorubicin - GnRH-III bioconjugate modified by apoptosis inducing agent butyric acid on colorectal carcinoma bearing mice.
Kapuvári B; Hegedüs R; Schulcz Á; Manea M; Tóvári J; Gacs A; Vincze B; Mező G
Invest New Drugs; 2016 Aug; 34(4):416-23. PubMed ID: 27146514
[TBL] [Abstract][Full Text] [Related]
5. Enhanced cellular uptake and in vitro antitumor activity of short-chain fatty acid acylated daunorubicin-GnRH-III bioconjugates.
Hegedüs R; Manea M; Orbán E; Szabó I; Kiss E; Sipos E; Halmos G; Mező G
Eur J Med Chem; 2012 Oct; 56():155-65. PubMed ID: 22967796
[TBL] [Abstract][Full Text] [Related]
6. In vitro degradation and antitumor activity of oxime bond-linked daunorubicin-GnRH-III bioconjugates and DNA-binding properties of daunorubicin-amino acid metabolites.
Orbán E; Mezo G; Schlage P; Csík G; Kulić Z; Ansorge P; Fellinger E; Möller HM; Manea M
Amino Acids; 2011 Jul; 41(2):469-83. PubMed ID: 20953647
[TBL] [Abstract][Full Text] [Related]
7. In-vivo antitumour effect of daunorubicin-GnRH-III derivative conjugates on colon carcinoma-bearing mice.
Manea M; Tóvári J; Tejeda M; Schulcz A; Kapuvári B; Vincze B; Mezo G
Anticancer Drugs; 2012 Jan; 23(1):90-7. PubMed ID: 21915040
[TBL] [Abstract][Full Text] [Related]
8. GnRH-III based multifunctional drug delivery systems containing daunorubicin and methotrexate.
Leurs U; Lajkó E; Mező G; Orbán E; Öhlschläger P; Marquardt A; Kőhidai L; Manea M
Eur J Med Chem; 2012 Jun; 52():173-83. PubMed ID: 22480495
[TBL] [Abstract][Full Text] [Related]
9. Enhanced enzymatic stability and antitumor activity of daunorubicin-GnRH-III bioconjugates modified in position 4.
Manea M; Leurs U; Orbán E; Baranyai Z; Öhlschläger P; Marquardt A; Schulcz Á; Tejeda M; Kapuvári B; Tóvári J; Mezo G
Bioconjug Chem; 2011 Jul; 22(7):1320-9. PubMed ID: 21668011
[TBL] [Abstract][Full Text] [Related]
10. Modification of daunorubicin-GnRH-III bioconjugates with oligoethylene glycol derivatives to improve solubility and bioavailability for targeted cancer chemotherapy.
Hegedüs R; Pauschert A; Orbán E; Szabó I; Andreu D; Marquardt A; Mező G; Manea M
Biopolymers; 2015 May; 104(3):167-77. PubMed ID: 25753049
[TBL] [Abstract][Full Text] [Related]
11. Anthracycline-GnRH derivative bioconjugates with different linkages: synthesis, in vitro drug release and cytostatic effect.
Schlage P; Mezo G; Orbán E; Bosze S; Manea M
J Control Release; 2011 Dec; 156(2):170-8. PubMed ID: 21864594
[TBL] [Abstract][Full Text] [Related]
12. Enhanced In Vitro Antitumor Activity of GnRH-III-Daunorubicin Bioconjugates Influenced by Sequence Modification.
Schuster S; Biri-Kovács B; Szeder B; Buday L; Gardi J; Szabó Z; Halmos G; Mező G
Pharmaceutics; 2018 Nov; 10(4):. PubMed ID: 30423956
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and in vitro biochemical evaluation of oxime bond-linked daunorubicin-GnRH-III conjugates developed for targeted drug delivery.
Schuster S; Biri-Kovács B; Szeder B; Farkas V; Buday L; Szabó Z; Halmos G; Mező G
Beilstein J Org Chem; 2018; 14():756-771. PubMed ID: 29719573
[TBL] [Abstract][Full Text] [Related]
14. Comparative in vitro biological evaluation of daunorubicin containing GnRH-I and GnRH-II conjugates developed for tumor targeting.
Szabó I; Bősze S; Orbán E; Sipos É; Halmos G; Kovács M; Mező G
J Pept Sci; 2015 May; 21(5):426-35. PubMed ID: 25908176
[TBL] [Abstract][Full Text] [Related]
15. Drug targeting to decrease cardiotoxicity - determination of the cytotoxic effect of GnRH-based conjugates containing doxorubicin, daunorubicin and methotrexate on human cardiomyocytes and endothelial cells.
Polgár L; Lajkó E; Soós P; Láng O; Manea M; Merkely B; Mező G; Kőhidai L
Beilstein J Org Chem; 2018; 14():1583-1594. PubMed ID: 30013686
[No Abstract] [Full Text] [Related]
16. Functional characterization and kinetic studies of an ancestral lamprey GnRH-III selective type II GnRH receptor from the sea lamprey, Petromyzon marinus.
Silver MR; Sower SA
J Mol Endocrinol; 2006 Jun; 36(3):601-10. PubMed ID: 16720727
[TBL] [Abstract][Full Text] [Related]
17. Comparative cell biological study of in vitro antitumor and antimetastatic activity on melanoma cells of GnRH-III-containing conjugates modified with short-chain fatty acids.
Lajkó E; Spring S; Hegedüs R; Biri-Kovács B; Ingebrandt S; Mező G; Kőhidai L
Beilstein J Org Chem; 2018; 14():2495-2509. PubMed ID: 30344773
[No Abstract] [Full Text] [Related]
18. Synthesis, enzymatic stability and in vitro cytostatic effect of Daunorubicin-GnRH-III derivative dimers.
Schreier VN; Mező G; Orbán E; Dürr C; Marquardt A; Manea M
Bioorg Med Chem Lett; 2013 Apr; 23(7):2145-50. PubMed ID: 23434423
[TBL] [Abstract][Full Text] [Related]
19. Apoptotic Effects of Drug Targeting Conjugates Containing Different GnRH Analogs on Colon Carcinoma Cells.
Lajkó E; Hegedüs R; Mező G; Kőhidai L
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500399
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, in vitro stability, and antiproliferative effect of d-cysteine modified GnRH-doxorubicin conjugates.
Li S; Zhao H; Chang X; Wang J; Zhao E; Yin Z; Mao X; Deng S; Hao T; Wang H; Yang Y
J Pept Sci; 2019 Jan; 25(1):e3135. PubMed ID: 30467919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
